Terbinafine-induced Toxic Epidermal Necrolysis in Pregnancy: A Case Report

Ramesh Lamichhane1, Mahendra Raj Pandey2, Ayushma Dhungana3

  • 1Department of Internal Medicine, Nepal Cardio Diabetes and Thyroid Center, Budhanilkantha, Kathmandu, Nepal.

Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on pregnancy outcomes. Common etiology of the condition includes medication triggered followed by mycoplasma infection. Almost one-third of cases are idiopathic. Despite the rarity of data, terbinafine causing toxic epidermal necrolysis has been reported. Toxic epidermal necrolysis manifests as a macule, erythema followed by a blister in the chest and spreading to other parts of the body. Removal of the offending agent and supportive management is the cornerstone of management. Here we report 22-year-old primipara pregnant women presenting with toxic epidermal necrolysis after 3 weeks of oral terbinafine use with good pregnancy outcomes.